With inhibition of mitochondrial Ca2+ entry through mtCaMKIIN leading to increased [Ca2+]cyto beyond the already elevated levels in T2D, the Erk1/2 pathway is activated. The gene discussed is MAPK3; the disease is type 2 diabetes mellitus.